UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:December 09,
Galera Therapeutics (NASDAQ:GRTX)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Galera Therapeutics Charts.
Galera Therapeutics (NASDAQ:GRTX)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Galera Therapeutics Charts.

Galera Therapeutics, Inc. News

Galera Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Updates
Thursday 28 March 2024 (1 month ago) • GlobeNewswire Inc.
Form 4 - Statement of changes in beneficial ownership of securities
Monday 26 February 2024 (2 months ago) • Edgar (US Regulatory)
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Tuesday 20 February 2024 (2 months ago) • Edgar (US Regulatory)
Form 3 - Initial statement of beneficial ownership of securities
Tuesday 16 January 2024 (3 months ago) • Edgar (US Regulatory)
Galera Reports Third Quarter 2023 Financial Results and Recent Corporate Updates
Tuesday 14 November 2023 (5 months ago) • GlobeNewswire Inc.
Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Monday 13 November 2023 (5 months ago) • Edgar (US Regulatory)
Galera Shares Halted After FDA Says Avasopasem Needs Additional Phase 3 Trial
Tuesday 31 October 2023 (6 months ago) • Dow Jones News
Form 8-K - Current report
Tuesday 31 October 2023 (6 months ago) • Edgar (US Regulatory)
Galera Announces Receipt of Type A Meeting Minutes and Strategic Update
Tuesday 31 October 2023 (6 months ago) • GlobeNewswire Inc.
Form 8-K - Current report
Tuesday 26 September 2023 (7 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Friday 22 September 2023 (7 months ago) • Edgar (US Regulatory)
Galera Schedules Type A Meeting with FDA to Discuss Next Steps for Avasopasem
Monday 18 September 2023 (7 months ago) • GlobeNewswire Inc.

More Galera Therapeutics, Inc. News Articles